Filtered By:
Management: Marketing
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 200 results found since Jan 2013.
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
GALWAY, Ireland--(Healthcare Sales & Marketing Network)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients, today announced that Robert Colloton has joined the companys senior management team as vice president of U.S. Sales a... Devices, Interventional, Neurology, PersonnelNeuravi, EmboTrap, Revascularization, stroke
Source: HSMN NewsFeed - July 25, 2016 Category: Pharmaceuticals Source Type: news
FDA OKs expansion of InVivo Therapeutics spinal scaffold study
InVivo Therapeutics (NSDQ:NVIV) said today that the FDA cleared an expansion of its Inspire study of its neuro-spinal scaffold, now set to enroll up to 20 patients, and announced the 9th and 10th implantation in the trial, though the 10th patient died of an unrelated stroke.
The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting.
The federal watchdog cleared the company to expand the trial for up to 20 evaluable patients. The decision came based off the review of 6-month safety data from the trial, InViv...
Source: Mass Device - July 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Spinal InVivo Therapeutics Corp. Source Type: news
The Economic Benefits Of Healthier Eating: Why Corporations Can Be Natural Allies To Promote Better Diets
Nutrition is at the heart of many of the most important issues in our lives. From nourished children to vibrant aging, from social justice to sustainability, how we eat plays a major role in our health, our culture, and our happiness.
Yet, we rarely consider the tremendous economic impact of our food choices. Suboptimal nutrition is the leading cause of poor health in the United States and globally, principally related to chronic diseases such as heart disease, stroke, obesity, diabetes, and several cancers. In many nations, the costs of healthcare dwarf other programs in the national budget. In the United States, nearly ...
Source: Healthy Living - The Huffington Post - July 1, 2016 Category: Consumer Health News Source Type: news
No more sneaking sugar into packaged foods
The iconic black-and-white Nutrition Facts label you find on packaged foods in the United States is getting its first makeover in two decades. The federal government decided last month to update the food label beginning in 2018 by listing how much sugar has been added to a product.
The current label lumps added sugar with naturally occurring sugars in the foods themselves, which is a deceptive practice, said Dr. John Swartzberg, a UC Berkeley clinical professor emeritus and editorial board chair of the UC Berkeley Wellness Letter. So listing added sugar “will hopefully guide people away from consuming products with a ...
Source: UCLA Newsroom: Health Sciences - June 30, 2016 Category: Universities & Medical Training Source Type: news
Coconut Oil: Why You Should Question the Hype
by Carra Richling
Coconut has become a popular and trendy "super food." Ever since some preliminary research started claiming that it can cure everything from heart disease to Alzheimer's, and even aid in weight loss, coconut products have flooded the market. They include coconut oils, margarines, milks, yogurts and ice cream, and many products are substituting in coconut oil in order to gain market value.
There is, however, still a dearth of validated scientific research on the benefits of coconut, so it remains unclear whether or not the trend is the result of marketing hype. For example, the Alzheimer's Association no...
Source: Healthy Living - The Huffington Post - June 22, 2016 Category: Consumer Health News Source Type: news
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
PRISM II study published in BMC Neurology adds to clinical evidence demonstrating NUEDEXTA efficacy for PBA across diverse neurological disorders
ALISO VIEJO, Calif., June 8, 2016 -- (Healthcare Sales & Marketing Network) -- Avanir Pharmaceuticals, Inc... Biopharmaceuticals, NeurologyAvanir Pharmaceuticals, Otsuka, NUEDEXTA, pseudobulbar affect
Source: HSMN NewsFeed - June 9, 2016 Category: Pharmaceuticals Source Type: news
Zynex Hires Vice President of Operations
LONE TREE, Colo., June 6, 2016 -- (Healthcare Sales & Marketing Network) -- Zynex (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodi... Devices, PersonnelZynex, electrotherapy, NeuroMove
Source: HSMN NewsFeed - June 6, 2016 Category: Pharmaceuticals Source Type: news
Prasugrel Use in Real Life: A Report From the Outpatient Setting in France
The objective of this study was to provide descriptive statistics on patterns of prasugrel usage in the outpatient setting in France. This retrospective study was conducted to describe treatment patterns for prasugrel in the outpatient setting in France using the Intercontinental Marketing Services (IMS) Disease Analyzer database, which collates electronic medical records updated by a nationally representative database of 1200 French general practitioners (GPs). Anonymous data were collected prospectively at each follow‐up visit. The study population consisted of patients with ≥1 prescription for prasugrel in the outpa...
Source: Clinical Cardiology - April 30, 2016 Category: Cardiology Authors: Pierre Sabouret, Magali Taiel‐Sartral, Florence Chartier, Sabine Akiki, Thomas Cuisset Tags: Quality and Outcomes Source Type: research
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7
RICHMOND, Calif., April 04, 2016 -- (Healthcare Sales & Marketing Network) -- Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced th... Devices, Neurology, FDAEkso Bionics, robotic exoskeleton, Ekso GT, stroke
Source: HSMN NewsFeed - April 4, 2016 Category: Pharmaceuticals Source Type: news
Pretty Much Nobody In The U.S. Leads A Healthy Lifestyle
Only 2.7 percent of U.S. adults hit the four key metrics of living a healthy lifestyle -- abstaining from smoking, eating well, exercising and maintaining a healthy body fat percentage -- according to a disheartening new study. The study's lifestyle benchmarks for health weren't particularly high. Being smoke-free, exercising moderately and eating USDA recommended foods don't seem like particularly difficult marks to hit. So why do so many Americans fall short of living healthy lives? "That is the million dollar question," Ellen Smit, a senior author of the study and an associate professor at the Oregon State Un...
Source: Science - The Huffington Post - March 25, 2016 Category: Science Source Type: news
Public Health and Citizens, Truly United
There are just two problems with the prevailing conception of "public health" -- the public, and health. Neither means what we think it means. For starters, there is no public. The public is an anonymous mass, a statistical conception, nameless, faceless, unknowable, and unlovable. I have made the case before that laboring under this crippling fiction, the potential good that all things "public health" might do is much forestalled. We talk, for instance, about the genuine potential to eliminate up to 80 percent of the total global burden of chronic disease -- heart disease, cancer, stroke, diabetes, dementia -- but somehow...
Source: Healthy Living - The Huffington Post - March 3, 2016 Category: Consumer Health News Source Type: news
Evolution of Pharmacological Obesity Treatments: Focus on Adverse Side‐Effect Profiles
ABSTRACT
Pharmacotherapy directed toward reducing body weight may provide benefits for both curbing obesity and lowering the risk of obesity‐associated co‐morbidities. However, many weight loss medications have been withdrawn from the market due to serious adverse effects. Examples include pulmonary hypertension (aminorex), cardiovascular toxicity, e.g. flenfluramine‐induced valvopathy, stroke (phenylpropanolamine), excess non‐fatal cardiovascular events (sibutramine), and neuro‐psychiatric issues (rimonabant ‐ approved in Europe, but not in the US). This negative experience has helped mold the current drug dev...
Source: Diabetes, Obesity and Metabolism - March 1, 2016 Category: Endocrinology Authors: Andrew J. Krentz, Ken Fujioka, Marcus Hompesch Tags: REVIEW ARTICLE Source Type: research
Brainlab invests nearly $8m into Jan Medical
Jan Medical said today it obtained $7.5 million in Series C funding from partner Brainlab Inc, with funds slated to aid in completion of a clinical trial and filing for de novo clearance with the FDA and CE Mark approval in the European Union for its BrainPulse tool.
Mountain View, Calif.-based Jan Medical’s BrainPulse device is designed to non-invasively capture novel physiological signals through a patient’s cardiac output, used to measure vascular and brain tissue conditions, the company said. The data can be used as an ‘aid to diagnoses’ for multiple indications, including concussion and stro...
Source: Mass Device - January 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular Diagnostics Regulatory/Compliance Brainlab Jan Medical Source Type: news
InspireMD CEO Milinazzo, CTO Bar to bow out | Personnel Moves
InspireMD (OTC:NSPR) said today that it’s looking for a replacement for CEO Alan Milinazzo as it looks to drill down on the largest markets for its CGuard and MGuard stents, which are designed to help prevent blood clots that can cause stroke.
Milinazzo agreed to stay on until either a replacement is found or June 30, whichever comes 1st. The new CEO will be hired to grow sales in Europe and improve the balance sheet, InspireMD said.
The Boston-based company said also said it tapped as vice chairman biotech legend Isaac Blech, the founder of Celgene (NSDQ:CELG), ICOS Corp., Pathogenesis, Nova Pharmaceutical and Gene...
Source: Mass Device - January 22, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Business/Financial News HemaFlo Therapeutics InspireMD Intuitive Surgical Inc. IsoRay RefleXion Medical Reva Medical Inc. Source Type: news
This Is By Far The Best Way To Avoid Lower Back Pain
By: Cari Nierenberg Published: 01/11/2016 06:35 PM EST on LiveScience Shoe inserts, back-support belts and other gadgets aimed at preventing low back pain may be a waste of money. Instead, exercise is the best way to ward off this common problem, a new review of studies suggests. The researchers found evidence that an exercise program alone, or exercise along with education about how to prevent back pain, was effective in averting an episode of low back pain and reducing people's use of sick time at work. Education may include receiving training in proper lifting techniques, learning about correct posture or attending...
Source: Science - The Huffington Post - January 12, 2016 Category: Science Source Type: news
